X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (32238) 32238
Newsletter (204) 204
Magazine Article (38) 38
Newspaper Article (15) 15
Publication (11) 11
Book Chapter (9) 9
Book Review (4) 4
Conference Proceeding (3) 3
Dissertation (2) 2
Reference (2) 2
Book / eBook (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28211) 28211
fluorouracil - administration & dosage (21657) 21657
female (19847) 19847
middle aged (17275) 17275
male (16567) 16567
antineoplastic combined chemotherapy protocols - therapeutic use (15312) 15312
aged (15045) 15045
oncology (14452) 14452
adult (12625) 12625
chemotherapy (9688) 9688
fluorouracil (9182) 9182
cancer (7457) 7457
treatment outcome (6749) 6749
5-fluorouracil (6010) 6010
cisplatin - administration & dosage (5663) 5663
antineoplastic combined chemotherapy protocols - adverse effects (5648) 5648
fluorouracil - therapeutic use (4954) 4954
fluorouracil - adverse effects (4928) 4928
leucovorin - administration & dosage (4844) 4844
combined modality therapy (4812) 4812
antineoplastic combined chemotherapy protocols - administration & dosage (4675) 4675
colorectal neoplasms - drug therapy (4514) 4514
drug administration schedule (4452) 4452
animals (3983) 3983
neoplasm staging (3930) 3930
breast neoplasms - drug therapy (3914) 3914
aged, 80 and over (3757) 3757
colorectal cancer (3742) 3742
deoxycytidine - analogs & derivatives (3563) 3563
chemotherapy, adjuvant (3491) 3491
survival rate (3487) 3487
adenocarcinoma - drug therapy (3389) 3389
prognosis (3384) 3384
capecitabine (3362) 3362
surgery (3312) 3312
disease-free survival (3304) 3304
leucovorin (3296) 3296
organoplatinum compounds - administration & dosage (3173) 3173
therapy (3131) 3131
fluorouracil - analogs & derivatives (3119) 3119
colorectal neoplasms - pathology (3052) 3052
oxaliplatin (2997) 2997
cyclophosphamide - administration & dosage (2991) 2991
carcinoma (2948) 2948
retrospective studies (2878) 2878
care and treatment (2848) 2848
deoxycytidine - administration & dosage (2847) 2847
antimetabolites, antineoplastic - administration & dosage (2831) 2831
pharmacology & pharmacy (2792) 2792
survival analysis (2753) 2753
cisplatin (2750) 2750
follow-up studies (2657) 2657
stomach neoplasms - drug therapy (2608) 2608
camptothecin - analogs & derivatives (2566) 2566
liver neoplasms - secondary (2536) 2536
survival (2536) 2536
antineoplastic agents - administration & dosage (2518) 2518
liver neoplasms - drug therapy (2500) 2500
radiotherapy (2488) 2488
methotrexate - administration & dosage (2429) 2429
neoplasm metastasis (2419) 2419
medicine & public health (2409) 2409
doxorubicin - administration & dosage (2312) 2312
trial (2298) 2298
mice (2259) 2259
research (2163) 2163
camptothecin - administration & dosage (2151) 2151
metastasis (2138) 2138
carcinoma, squamous cell - drug therapy (2121) 2121
time factors (2090) 2090
prospective studies (1994) 1994
infusions, intravenous (1949) 1949
irinotecan (1918) 1918
colonic neoplasms - drug therapy (1904) 1904
breast neoplasms - pathology (1868) 1868
antineoplastic agents - therapeutic use (1861) 1861
fluorouracil - pharmacology (1847) 1847
dose-response relationship, drug (1842) 1842
breast cancer (1774) 1774
analysis (1719) 1719
bevacizumab (1682) 1682
drug therapy, combination (1626) 1626
antimetabolites, antineoplastic - therapeutic use (1606) 1606
lymphatic metastasis (1602) 1602
combination (1582) 1582
drug therapy (1492) 1492
stomach neoplasms - pathology (1480) 1480
administration, oral (1466) 1466
neoadjuvant therapy (1449) 1449
adenocarcinoma - pathology (1448) 1448
toxicity (1399) 1399
infusions, intra-arterial (1385) 1385
1st-line treatment (1383) 1383
chemoradiotherapy (1380) 1380
tumors (1379) 1379
clinical trials as topic (1367) 1367
randomized-trial (1363) 1363
phase-ii (1356) 1356
health aspects (1338) 1338
hematology, oncology and palliative medicine (1332) 1332
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (28847) 28847
Japanese (2995) 2995
German (515) 515
French (481) 481
Chinese (431) 431
Russian (307) 307
Italian (142) 142
Spanish (107) 107
Polish (63) 63
Hungarian (29) 29
Portuguese (23) 23
Czech (17) 17
Dutch (15) 15
Korean (15) 15
Norwegian (12) 12
Romanian (11) 11
Danish (10) 10
Hebrew (10) 10
Slovak (8) 8
Ukrainian (8) 8
Bulgarian (7) 7
Swedish (6) 6
Croatian (5) 5
Lithuanian (5) 5
Serbian (4) 4
Arabic (3) 3
Turkish (3) 3
Finnish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane library, ISSN 1465-1858, 2017, Volume 2017, Issue 8, pp. CD004064 - CD004064
Background Gastric cancer is the fifth most common cancer worldwide. In "Western" countries, most people are either diagnosed at an advanced stage, or develop... 
Camptothecin | Stomach | Anthracyclines | Gastroenterology & hepatology | Cancer: other gastrointestinal | Palliation | Docetaxel | Antineoplastic Combined Chemotherapy Protocols | Cisplatin | Randomized Controlled Trials as Topic | Irinotecan | Chemotherapy | Treatment | Taxoids | Stomach Neoplasms | Medicine General & Introductory Medical Sciences | Fluorouracil | Cancer | 1ST-LINE TREATMENT | OLDER-ADULT PATIENTS | COLONY-STIMULATING FACTOR | Humans | Anthracyclines [administration & dosage] | Cisplatin [administration & dosage] | HIGH-DOSE 5-FLUOROURACIL | Fluorouracil [administration & dosage] | MEDICINE, GENERAL & INTERNAL | analogs & derivatives | RANDOMIZED PHASE-II | ADVANCED GASTROINTESTINAL CANCER | mortality | Taxoids [administration & dosage] | Antineoplastic Combined Chemotherapy Protocols [therapeutic use] | QUALITY-OF-LIFE | GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA | Camptothecin [administration & dosage | Stomach Neoplasms [drug therapy | S-1 PLUS CISPLATIN | COOPERATIVE-ONCOLOGY-GROUP | Stomach Neoplasms - drug therapy | Cisplatin - administration & dosage | Taxoids - administration & dosage | Anthracyclines - administration & dosage | Fluorouracil - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Camptothecin - administration & dosage | Stomach Neoplasms - mortality | Camptothecin - analogs & derivatives | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 9, pp. 869 - 878
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 5, pp. 499 - 508
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 07/2017, Volume 2017, Issue 8, p. CD008398
Background Patients prefer oral to intravenous (IV) palliative chemotherapy, provided that oral therapy is not less effective. We compared the efficacy and... 
Camptothecin | Injections, Intravenous | Capecitabine | Organoplatinum Compounds | Tegafur | Palliative Care | Adjuvant therapy | Floxuridine | Neoplastic diseases of the colon | Pyrimidines | Colorectal Neoplasms | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Fluorouracil | Neoplastic diseases of the rectum and anus | Pyridines | Colorectal | Administration, Oral | Gastroenterology & hepatology | Antineoplastic Agents | Cancer: colorectal | Randomized Controlled Trials as Topic | Irinotecan | Treatment | Medical & adjuvant therapy | Disease‐Free Survival | Medicine General & Introductory Medical Sciences | Uracil | Cancer | COLON-CANCER | NON-INFERIORITY | 1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | SURGICAL ADJUVANT BREAST | RANDOMIZED PHASE-II | FOLFIRI FOLINIC ACID | RISK STAGE-II | CAPECITABINE PLUS OXALIPLATIN | ADVANCED RECTAL-CANCER | COOPERATIVE-ONCOLOGY-GROUP | Capecitabine - administration & dosage | Humans | Male | Antineoplastic Agents - administration & dosage | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Uracil - administration & dosage | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | Adult | Camptothecin - administration & dosage | Female | Floxuridine - administration & dosage | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Pyridines - administration & dosage | Pyrimidines - administration & dosage | Disease-Free Survival | Tegafur - administration & dosage | Colorectal Neoplasms - pathology | Uracil - analogs & derivatives
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1306 - 1315
Summary Background In the TRIBE study, FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, and irinotecan) plus bevacizumab significantly improved... 
Hematology, Oncology and Palliative Medicine | TRIAL | CETUXIMAB | SURROGATE | LEUCOVORIN | ONCOLOGY | END-POINT | PROGRESSION-FREE SURVIVAL | RAS MUTATIONS | GUIDELINES | KRAS | FLUOROURACIL | Leucovorin - administration & dosage | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Bevacizumab - therapeutic use | Bevacizumab - adverse effects | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Angiogenesis Inhibitors - administration & dosage | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Angiogenesis Inhibitors - therapeutic use | Camptothecin - administration & dosage | Female | Angiogenesis Inhibitors - adverse effects | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Bevacizumab - administration & dosage | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Proto-Oncogene Proteins - genetics | Treatment Outcome | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Intention to Treat Analysis | Italy | Aged | Infusions, Intravenous | Mutation | Colorectal Neoplasm